|
|
Kazuhiko Takahashi, Hiroaki Suwa, Tomoo Ishikawa, Hidehito Kotani
J Clin Invest. 2002;
110(12):1791
doi:10.1172/JCI15784
Abstract |
Full text
| PDF

H
istamine is an aminergic neurotransmitter that is localized in the CNS and in peripheral tissues. To date, four histamine receptors have been identified, and the H3 receptor, which was recently cloned, is predominantly expressed in the CNS. The peripheral functions of histamine have been investigated intensively using available molecular and pharmacological tools, and the molecular identification of the H3 receptor opens up new possibilities for investigating the role of histamine in central tissues. To understand the biological function of the histamine presynaptic autoreceptor H3, we inactivated the receptor through homologous recombination. H3–/– mice manifest mild obese phenotypes that are characterized by increases in body weight, food intake, and adiposity and by reductions in energy expenditure. Consistent with these observations, homozygous null mice have insulin and leptin resistance, increased levels of plasma leptin and insulin, and decreased levels of histamine in the hypothalamic/thalamic region of their brains coupled with increased histamine turnover. The expression of UCP1 in brown adipose tissue and of UCP3 in brown adipose tissue, white adipose tissue, and skeletal muscle is decreased in H3–/– mutants, and the anorexigenic activity of thioperamide is not observed. These results suggest that neuronal histamine is a mediator of body-weight homeostasis and that neuronal histamine functions through H3 receptors in mice.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(17)
| Title and authors |
Publication |
Year |
Folia Pharmacologica Japonica
Shigeru Tokita
|
Folia Pharmacol. Jpn.
|
2007 |
Roles of central histaminergic system in glucose metabolisms and food intake in sheep
Yohei KUROSE, Yoshiaki TERASHIMA
|
Animal Sci J
|
2007 |
Histamine and the Regulation of Body Weight
Emilie A. Jørgensen, Ulrich Knigge, Jørgen Warberg, Andreas Kjær
|
Neuroendocrinology
|
2007 |
Adiposopathy: Treating pathogenic adipose tissue to reduce cardiovascular disease risk
Harold Bays, Helena W. Rodbard, Alan Bruce Schorr, J. Michael González-Campoy
|
Curr Treat Options Cardio Med
|
2007 |
Obesity drugs and their targets: correlation of mouse knockout phenotypes with drug effects in vivo
D. R. Powell
|
Obesity Reviews
|
2006 |
Weight loss in overweight patients maintained on atypical antipsychotic agents
F Centorrino, J J Wurtman, K A Duca, V H Fellman, K V Fogarty, J M Berry, D M Guay, M Romeling, J Kidwell, S L Cincotta, R J Baldessarini
|
Int J Obes Relat Metab Disord
|
2006 |
Therapeutic potential of histamine H3 receptor agonist for the treatment of obesity and diabetes mellitus.
Ryo Yoshimoto, Yasuhisa Miyamoto, Ken Shimamura, Akane Ishihara, Kazuhiko Takahashi, Hidehito Kotani, Airu S Chen, Howard Y Chen, Douglas J Macneil, Akio Kanatani, Shigeru Tokita
|
Proc. Natl. Acad. Sci. U.S.A.
|
2006 |
Recent Advances in Molecular Pharmacology of the Histamine Systems: Physiology and Pharmacology of Histamine H3 Receptor: Roles in Feeding Regulation and Therapeutic Potential for Metabolic Disorders
Shigeru Tokita, Kazuhiko Takahashi, Hidehito Kotani
|
J Pharmacol Sci
|
2006 |
Targeting of the central histaminergic system for treatment of obesity and associated metabolic disorders
Kjell Malmlöf, Rolf Hohlweg, Karin Rimvall
|
Drug Dev. Res.
|
2006 |
Assessment of pharmacology and potential anti-obesity properties of H3receptor antagonists/inverse agonists
Arthur A Hancock, Michael E Brune
|
Expert Opin. Investig. Drugs
|
2005 |
|